IGF2 and cancer: Our study shows that there are two prevailing mechanisms of predisposition to bilateral WT: either germline genetic alterations acting through mutant WT1, TRIM28, and a small number of additional WT and general cancer genes; or to a slightly lesser extent, postzygotic mosaic imprinting defects of BWS-IC1, which controls IGF2 expression.